soul trial oral semaglutide cardiovascular outcomes results 2025 The impact of on events in patients with type 2 diabetes: review of from the SOUL trial shows oral semaglutide

The GLP-1 targeted peptide weight loss drugs market refers to the segment of pharmaceuticals that utilize glucagon-like peptide-1 (GLP-1) receptor agonists to promote weight loss and improve metabolic health

Content note: This episode discusses eating disorders, weight stigma, and medical harm

They act as messengers, signaling specific glands and proteins into performing specific tasks

In a meta-analysis involving 3087 obese individuals without diabetes, it resulted in an average weight loss difference of 12.3 kg (12.1%) compared to a placebo for an average duration of 77 weeks

The South Korean government, under the "Act on the Protection and Settlement Support of North Korean Defectors," provides comprehensive settlement assistance, including education, employment support, medical care, and housing